Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1995 1
1996 3
1998 2
1999 2
2001 3
2002 1
2003 5
2004 2
2005 4
2006 5
2007 3
2008 4
2009 6
2010 2
2011 3
2012 7
2013 5
2014 2
2015 2
2016 3
2017 3
2018 2
2019 1
2020 4
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent.
Gioelli N, Maione F, Camillo C, Ghitti M, Valdembri D, Morello N, Darche M, Zentilin L, Cagnoni G, Qiu Y, Giacca M, Giustetto M, Paques M, Cascone I, Musco G, Tamagnone L, Giraudo E, Serini G. Gioelli N, et al. Among authors: serini g. Sci Transl Med. 2018 May 23;10(442):eaah4807. doi: 10.1126/scitranslmed.aah4807. Sci Transl Med. 2018. PMID: 29794061 Free article.
Class 3 semaphorins in cardiovascular development.
Valdembri D, Regano D, Maione F, Giraudo E, Serini G. Valdembri D, et al. Among authors: serini g. Cell Adh Migr. 2016 Nov;10(6):641-651. doi: 10.1080/19336918.2016.1212805. Epub 2016 Jul 20. Cell Adh Migr. 2016. PMID: 27439112 Free PMC article. Review.
Semaphorins and tumor angiogenesis.
Serini G, Maione F, Giraudo E, Bussolino F. Serini G, et al. Angiogenesis. 2009;12(2):187-93. doi: 10.1007/s10456-009-9138-4. Epub 2009 Mar 6. Angiogenesis. 2009. PMID: 19266292 Review.
Semaphoring vascular morphogenesis.
Bussolino F, Valdembri D, Caccavari F, Serini G. Bussolino F, et al. Among authors: serini g. Endothelium. 2006 Mar-Apr;13(2):81-91. doi: 10.1080/10623320600698003. Endothelium. 2006. PMID: 16728327 Review.
Increasing traffic on vascular routes.
Santambrogio M, Valdembri D, Serini G. Santambrogio M, et al. Among authors: serini g. Mol Aspects Med. 2011 Apr;32(2):112-22. doi: 10.1016/j.mam.2011.04.003. Epub 2011 Apr 23. Mol Aspects Med. 2011. PMID: 21536065 Review.
75 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page